Show simple item record

dc.contributor.authorStewart, Trinaen_US
dc.description.abstractThe role of natural killer T (NKT) cells in the immune response to tumor cells has been largely unexplored. As a model of adoptive tumor immunotherapy, cells from the draining lymph nodes of mice immunized with a tumor-specific or irrelevant antigen were transferred to naı¨ve recipients with established tumor. Inhibition of early tumor growth (day 4) required the transfer of both CD8 and Ja18 (NKT) cells from immunized animals without regard to immunogen. In contrast, CD8 cells, but not Ja18 cells, were necessary for the inhibition of late tumor growth (day 8). Thus, the developing tumor changes in sensitivity to NKT-mediated events and the role for NKT cells cannot be replaced by the presence of tumor-specific cells during early tumor growth. This suggests that recruitment/activation of Ja18 NKT cells is an important consideration during the immune therapy of early stage tumors.en_US
dc.publisherAmerican Association for Cancer Researchen_US
dc.publisher.placeUnited States of Americaen_US
dc.relation.ispartofjournalCancer Researchen_US
dc.subject.fieldofresearchTumour Immunologyen_US
dc.titleInhibition of Early Tumor Growth Requires Ja18-positive (Natural Killer T) Cellsen_US
dc.typeJournal article
dc.type.descriptionJournal Articles (Refereed Article)en_US
gro.facultyGriffith Health Facultyen_US
gro.hasfulltextNo Full Text
gro.griffith.authorStewart, Trina

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record